Literature DB >> 11175978

Safety of endoscopy in patients with end-stage liver disease.

B M McGuire1.   

Abstract

Patients with end-stage liver disease routinely undergo an upper endoscopy for the diagnosis and management of complications of portal hypertension. These cirrhotic patients inherently have additional risks and higher rates of complications secondary to their liver disease and the presence of portal hypertension. Additional considerations and precautions must be taken into account to ensure that the endoscopic procedure is performed with the minimal risks possible. This article discusses the management of cirrhotic patients undergoing endoscopy. It addresses clinical clues for identifying the cirrhotic patient, the use of medications and monitoring equipment for vital signs during endoscopy, blood product administration in acute upper gastrointestinal bleeding, and elective and urgent procedures to diagnose and treat cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175978

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  8 in total

1.  The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis.

Authors:  Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Kwan Mi Pack; Jae Myung Cha; Jae Jun Park; Jun Uk Lim; Kyuseong Lim
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

2.  Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy.

Authors:  Abhinandana Anantharaju; Kapil Mehta; Ayse L Mindikoglu; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  Propofol is a more effective and safer sedative agent than midazolam in endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis: a randomized controlled trial.

Authors:  Ko Watanabe; Takuto Hikichi; Tadayuki Takagi; Rei Suzuki; Jun Nakamura; Mitsuru Sugimoto; Hitomi Kikuchi; Naoki Konno; Mika Takasumi; Yuki Sato; Minami Hashimoto; Hiroki Irie; Katsutoshi Obara; Hiromasa Ohira
Journal:  Fukushima J Med Sci       Date:  2018-10-21

4.  Safety and effectiveness of low-dose propofol sedation during and after esophagogastroduodenoscopy in child A and B cirrhotic patients.

Authors:  Naoki Tanaka; Akira Horiuchi; Yoshiko Nakayama; Yoshihiko Katsuyama; Masatsugu Isobe; Toshifumi Aoyama; Eiji Tanaka; Shigeru Ohmori
Journal:  Dig Dis Sci       Date:  2012-11-21       Impact factor: 3.199

5.  Safety profile of sedative endoscopy including cognitive performance in liver cirrhosis: A double-blind randomized controlled trial.

Authors:  Jeong-Ju Yoo; Hyeon Jeong Goong; Ji Eun Moon; Sang Gyune Kim; Young Seok Kim
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

6.  RLLB/Alb ratio: a promising noninvasive diagnostic marker in assessing esophageal varices in cirrhotic patients.

Authors:  Md Faisal Fahad Chowdhury; Ashekul Islam; Pulak Kanti Palit; Md Mozibullah; Md Sohel; Mst Mahmuda Khatun; Mohammed Mehadi Hassan Chowdhury; Mohammod Johirul Islam; Joyonti Datta; Suman Dhar; Pradip Kumar Nath; Sabuj Kanti Nath
Journal:  J Clin Lab Anal       Date:  2022-07-08       Impact factor: 3.124

7.  Current and Future Use of Esophageal Capsule Endoscopy.

Authors:  Junseok Park; Young Kwan Cho; Ji Hyun Kim
Journal:  Clin Endosc       Date:  2018-07-31

Review 8.  Gastrointestinal endoscopy in cirrhotic patient: Issues on the table.

Authors:  Giuseppe Grassi; Ilaria Lenci; Alessandro Signorello; Martina Milana; Leonardo Baiocchi
Journal:  World J Gastrointest Endosc       Date:  2021-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.